Omega-3 Supplement and Health Markers
Public ClinicalTrials.gov record NCT06492694. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of a Fish Oil-based, Essential-oil Infused Supplement on Markers of Health
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to learn whether fish oil-based supplements can affect gene expression and serum protein markers in healthy volunteers. The main questions it aims to answer are: 1. How does daily ingestion of fish oil supplements affect gene expression, omega-3 levels, and protein markers as measured in blood? 2. How does daily ingestion of fish oil supplements affect anthropometric measurements? 3. How does daily ingestion of fish oil supplements affect subjective quality of life and health parameters? 4. Do fish oil + wild orange essential oil supplements produce different outcomes than fish oil supplements alone? 5. Is ingesting fish oil supplements daily safe, as measured by laboratory tests and adverse events? Researchers will compare two types of fish oil supplements. One type contains fish oil and wild orange essential oil as its active ingredients. The other type contains only fish oil as its active ingredient. Participants will: * Be assigned one of the two types of fish oil supplements * Take three softgels of their assigned supplement every day for about six weeks * Attend two study visits in which they provide blood and urine samples, complete subjective health and quality of life assessments, and undergo anthropometric measurements * Complete weekly subjective health assessments from home
Study identification
- NCT ID
- NCT06492694
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 55 participants
Conditions and interventions
Conditions
Interventions
- Fish oil + wild orange essential oil supplement Dietary Supplement
- Fish oil supplement Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 9, 2024
- Primary completion
- Aug 27, 2024
- Completion
- Sep 2, 2024
- Last update posted
- Jan 7, 2025
2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| doTERRA International | Pleasant Grove | Utah | 84062 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06492694, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2025 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06492694 live on ClinicalTrials.gov.